ad
This Article
Right arrow Images Only
Right arrow Full Version
Services
Right arrow E-mail this link to a friend
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices
Right arrow Earn CME - What's This?
Related Collections
Right arrowRelated Articles

The first 300 words of the full text of this section appear below.

Section 3. Summaries of Infectious Diseases

Hepatitis A

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures
Recommendations for Immunoprophylaxis

CLINICAL MANIFESTATIONS

Hepatitis A characteristically is an acute, self-limited illness associated with fever, malaise, jaundice, anorexia, and nausea. Symptomatic hepatitis A virus (HAV) infection occurs in approximately 30% of infected children younger than 6 years of age; few of these children will have jaundice. Among older children and adults, infection usually is symptomatic and typically lasts several weeks, with jaundice occurring in 70% or more. Signs and symptoms typically last less than 2 months, although 10% to 15% of symptomatic people have prolonged or relapsing disease lasting as long as 6 months. Fulminant hepatitis is rare but is more common in people with underlying liver disease. Chronic infection does not occur.


ETIOLOGY

HAV is an RNA virus classified as a member of the picornavirus group.


EPIDEMIOLOGY

The most common mode of transmission is person to person, resulting from fecal contamination and oral ingestion (ie, the fecal-oral route). In developing countries, where infection is endemic, most people are infected during the first decade of life. In the United States, hepatitis A was one of the most frequently reported vaccine-preventable diseases in the prevaccine era, but incidence of disease attributable to HAV has declined since hepatitis A vaccine was licensed in 1995. In 2007, 2979 cases were reported to the Centers for Disease Control and Prevention (CDC), compared with 22 000 to 36 000 hepatitis A cases reported annually from 1980 through 1995. These declining rates have been accompanied by a shift in age-specific rates. Historically, the highest rates occurred among children 5 to 14 years of age, and the lowest rates occurred among adults older than 40 years of age. Beginning in the late 1990s, national . . . [Go to Full Text]


Related Articles

Summary of Major Changes in the 2009 Red Book
Red Book 2009 2009: XXIX. [Extract] [Full Text]

Active Immunization of People Who Recently Received Immune Globulin
Red Book 2009 2009: 37. [Extract] [Full Text]

Scheduling Immunizations
Red Book 2009 2009: 21-31. [Extract] [Full Text]

Simultaneous Administration of Multiple Vaccines
Red Book 2009 2009: 33-34. [Extract] [Full Text]

Immune Globulin (Intramuscular)
Red Book 2009 2009: 56-57. [Extract] [Full Text]

International Travel
Red Book 2009 2009: 98-104. [Extract] [Full Text]

Immunocompromised Children
Red Book 2009 2009: 72-86. [Extract] [Full Text]

Children With Chronic Diseases
Red Book 2009 2009: 86a-87a. [Extract] [Full Text]

Active Immunization After Exposure to Disease
Red Book 2009 2009: 87-88. [Extract] [Full Text]

Children in Residential Institutions
Red Book 2009 2009: 90-92. [Extract] [Full Text]

Transfusion-Transmitted Agents: Known Threats and Potential Pathogens
Red Book 2009 2009: 108a-116a. [Extract] [Full Text]

Recommendations for Inclusion or Exclusion
Red Book 2009 2009: 127-131. [Extract] [Full Text]

Infectious Diseases—Epidemiology and Control
Red Book 2009 2009: 131-138. [Extract] [Full Text]

Diseases Preventable by Routine Childhood Immunization
Red Book 2009 2009: 141-142. [Extract] [Full Text]

Infections Spread by the Fecal-Oral Route
Red Book 2009 2009: 145. [Extract] [Full Text]

STIs in Adolescents
Red Book 2009 2009: 163-165. [Extract] [Full Text]

Hepatitis A
Red Book 2009 2009: 173-174. [Extract] [Full Text]